73 related articles for article (PubMed ID: 1298313)
1. [Serum beta 2-microglobulin determination in nasopharyngeal carcinoma patients. An analysis of 139 cases].
Luo ZM
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(4):239-40, 256. PubMed ID: 1298313
[TBL] [Abstract][Full Text] [Related]
2. Beta-2-microglobulin (beta 2M) as a tumor marker in nasopharyngeal carcinoma.
Lee JK; Tsai SC; Hsieh JF; Ho YJ; Sun SS; Kao CH
Anticancer Res; 2000; 20(6C):4765-8. PubMed ID: 11205215
[TBL] [Abstract][Full Text] [Related]
3. [Plasma prostaglandins E, E2 and F2a in nasopharyngeal carcinoma (NPC)].
Chen BS
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):248-50. PubMed ID: 2625103
[TBL] [Abstract][Full Text] [Related]
4. Comparison of CYFRA 21-1 and tissue polypeptide specific antigen (TPS) for detecting nasopharyngeal carcinoma.
Tai CJ; Liu FY; Liang JA; Yang SN; Tsai MH; Kao CH
Anticancer Res; 2002; 22(6B):3793-6. PubMed ID: 12552995
[TBL] [Abstract][Full Text] [Related]
5. Serum beta-2-microglobulin in African Burkitt tumour, nasopharyngeal carcinoma and controls.
Cooper EH; Kerruish SM; Gunvèn P
Biomedicine; 1981 Jul; 35(3):104-7. PubMed ID: 6168307
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of elevated serum sICAM-1 in patients with nasopharyngeal carcinoma].
Wang L; Shu M; Wei Q
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Dec; 35(6):469-71. PubMed ID: 12768764
[TBL] [Abstract][Full Text] [Related]
7. Tissue polypeptide specific antigen (TPS) as a tumor marker in nasopharyngeal carcinoma.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(6C):4661-3. PubMed ID: 11205197
[TBL] [Abstract][Full Text] [Related]
8. [Serum acute phase proteins in nasopharyngeal carcinoma and laryngeal cancers].
Chen P
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1989; 24(3):174-6, 190. PubMed ID: 2484505
[TBL] [Abstract][Full Text] [Related]
9. [Detection of bate 2-microglobulin fibronection and interleukin 2 content in patients with nasopharyngeal carcinoma].
Lin Q; Fu F; Zhang G
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Nov; 15(11):499-500. PubMed ID: 12541829
[TBL] [Abstract][Full Text] [Related]
10. [Dynamic observation on serum sialic acid in nasopharyngeal carcinoma patients].
Zhang HQ; Zhou ZB; Fan L; Jin F; Fei Y; Li XH; Zhao HY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Jun; 40(6):411-4. PubMed ID: 16144331
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
[TBL] [Abstract][Full Text] [Related]
12. [Measurement of serum neopterin levels in patients with nasopharyngeal carcinoma and its significance].
Wang L; Jin S; Wei Q; Xiang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 May; 15(5):204-5. PubMed ID: 12541762
[TBL] [Abstract][Full Text] [Related]
13. Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy.
Ma BB; Leungm SF; Hui EP; Mo F; Kwan WH; Zee B; Yuen J; Chan AT
Cancer; 2004 Aug; 101(4):776-81. PubMed ID: 15305409
[TBL] [Abstract][Full Text] [Related]
14. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
[TBL] [Abstract][Full Text] [Related]
15. [The study on the role of telomerase activity in human nasopharyngeal carcinoma].
Peng H; Wang X; Yang G; Jiang S; Zhao T
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Aug; 35(4):289-91. PubMed ID: 12768708
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of beta 2-microglobulin content in nasopharyngeal secretion].
Cui D; Su M; Jie Y
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Jun; 32(3):148-50. PubMed ID: 10743152
[TBL] [Abstract][Full Text] [Related]
17. [Significance of detection of serum sialic acid and Epstein-Barr virus VCA-IgA in diagnosis and monitoring radiotherapy effectiveness in nasopharyngeal carcinoma patients].
Jiang LN; Dai LC; He JF; Chen YW; Ma ZH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):30-2. PubMed ID: 16816858
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus serological markers for nasopharyngeal carcinoma in Thailand.
Puthavathana P; Sutthent R; Vitavasiri A; Wasi C; Chantarakul N; Thongcharoen P
Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):326-31. PubMed ID: 1818381
[TBL] [Abstract][Full Text] [Related]
19. [Expression of telomerase and its RNA in nasopharyngeal carcinoma].
Wen Z; Xiao J; Tang F; Tian Y; Zhao S; Chen B
Chin Med J (Engl); 2000 Jun; 113(6):525-8. PubMed ID: 11775871
[TBL] [Abstract][Full Text] [Related]
20. [Clinical value of vascular endothelial growth factor detection in forecasting distant metastasis risk of nasopharyngeal carcinoma].
Guo X; Cao SM; Hong MH; Zhang CQ; Han AJ; Xiang YQ; Hou JH; Min HQ
Ai Zheng; 2004 Oct; 23(10):1171-5. PubMed ID: 15473929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
